podcasts / All-In with Chamath, Jason, Sacks & Friedberg / episode / question
Question

What does Will Ahmed say people on GLP-1 drugs should watch for with WHOOP?

Answered from WHOOP CEO, Will Ahmed: 50B Hours of Health Data, a 4 Million Member Data Moat, & the FDA Fight · All-In with Chamath, Jason, Sacks & Friedberg · 2026-10-29

Will Ahmed said that typically about half the weight people lose on GLP-1 drugs is fat and half is muscle, which can leave them frail. WHOOP's GLP-1 tracker uses that knowledge to push members toward activity and strength training, even body-weight work, plus adequate protein. He also mentioned anecdotal reports of people taking creatine while on GLP-1s. Jason Calacanis said the tracker set him targets of 9,800 steps, two strength sessions a week, daily hydration and protein.

Source: our own transcription of the episode. The full conversation is on All-In with Chamath, Jason, Sacks & Friedberg (2026-10-29). Read the whole episode summary →

▸More from this episode

Q1Why did Will Ahmed switch WHOOP from a $500 device to a monthly subscription?Q2What did Will Ahmed say about the FDA warning letter over WHOOP's blood pressure feature?Q3How does WHOOP CEO Will Ahmed explain heart rate variability?Q4What is WHOOP doing with its 50 billion hours of health data, according to Will Ahmed?Q5How did WHOOP warn Jason Calacanis about his health before going to the ER?Q7Why did LeBron James become a WHOOP global ambassador?Q8What are Will Ahmed's picks on cold plunges, saunas, lifting and morning coffee?
Transcribe your links. Paste a YouTube, Google Drive or podcast link and WhipScribe gives you the transcript. Transcribe a link →